Sign up to the UK Share Picking Game

Oxford Biomedica (OXB) Health Care Sector

Latest Quote Price

Price Change (%)

Trading Velocity

Activity Score

Momentum Score

Consensus Score


Latest Bid : Latest Ask :
High Today : Low Today :
This Years High : This Years Low :
Volume : MKT Cap :

Stock Splits and Consolidations

30/05/2018 – Stock Consolidation 50.000:1.000


Oxford Biomedica Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

Latest Oxford Biomedica Tips

Type Tipster SectorScore Start date Performance
RBC Capital 2022-07-01 07:13:00 01/07/2022
RBC Capital 2022-06-30 18:00:00 30/06/2022
RBC Capital 2022-06-21 18:00:00 21/06/2022
Alan Oscroft 2022-06-14 08:30:00 14/06/2022
RBC Capital 2022-05-23 09:31:00 23/05/2022

Oxford Biomedica Data Charts

Premium Charts

Latest Bid : Latest Ask :
High Today : Low Today :
This Years High : This Years Low :
Volume : MKT Cap :

Oxford Biomedica Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

Latest Oxford Biomedica Tips

Type Tipster SectorScore Start date Performance
RBC Capital 2022-07-01 07:13:00 01/07/2022
RBC Capital 2022-06-30 18:00:00 30/06/2022
RBC Capital 2022-06-21 18:00:00 21/06/2022
Alan Oscroft 2022-06-14 08:30:00 14/06/2022
RBC Capital 2022-05-23 09:31:00 23/05/2022

Stock Splits and Consolidations

30/05/2018 – Stock Consolidation 50.000:1.000